Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification
Open Access
- 2 August 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 26 (11) , 2647-2655
Abstract
Human genetic disorders sharing the common feature of subcutaneous heterotopic ossification (HO) are caused by heterozygous inactivating mutations in GNAS, a gene encoding multiple transcripts including two stimulatory G proteins, the α subunit of the stimulatory G protein (Gsα) of adenylyl cyclase, and the extralong form of Gsα, XLαs. In one such disorder, progressive osseous heteroplasia (POH), bone formation initiates within subcutaneous fat before progressing to deeper tissues, suggesting that osteogenesis may involve abnormal differentiation of mesenchymal precursors that are present in adipose tissues. We determined by immunohistochemical analysis that GNAS protein expression is limited to Gsα in bone‐lining cells and to Gsα and XLαs in osteocytes. By contrast, the GNAS proteins Gsα, XLαs, and NESP55 are detected in adipocytes and in adipose stroma. Although Gnas transcripts, as assessed by quantitative RT‐PCR, show no significant changes on osteoblast differentiation of bone‐derived precursor cells, the abundance of these transcripts is enhanced by osteoblast differentiation of adipose‐derived mesenchymal progenitors. Using a mouse knockout model, we determined that heterozygous inactivation of Gnas (by disruption of the Gsα‐specific exon 1) abrogates upregulation of multiple Gnas transcripts that normally occurs with osteoblast differentiation in wild‐type adipose stromal cells. These transcriptional changes in Gnas+/− mice are accompanied by accelerated osteoblast differentiation of adipose stromal cells in vitro. In vivo, altered osteoblast differentiation in Gnas+/− mice manifests as subcutaneous HO by an intramembranous process. Taken together, these data suggest that Gnas is a key regulator of fate decisions in adipose‐derived mesenchymal progenitor cells, specifically those which are involved in bone formation. © 2011 American Society for Bone and Mineral ResearchKeywords
This publication has 36 references indexed in Scilit:
- Inherited human diseases of heterotopic bone formationNature Reviews Rheumatology, 2010
- GNAS-associated disorders of cutaneous ossification: Two different clinical presentationsBone, 2010
- Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS‐based heterotopic ossificationAmerican Journal of Medical Genetics Part A, 2008
- Mesodermal fate decisions of a stem cell: the Wnt switchCellular and Molecular Life Sciences, 2008
- Physiological functions of the imprinted Gnas locus and its protein variants Gαs and XLαs in human and mouseJournal of Endocrinology, 2007
- Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosisAging Cell, 2007
- Studies of the regulation and function of the Gsα gene Gnas using gene targeting technologyPharmacology & Therapeutics, 2007
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Progressive Osseous HeteroplasiaJournal of Bone and Mineral Research, 2000
- Differentiation of Human Marrow Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances Osteoblast Commitment, and Inhibits Late Adipocyte MaturationJournal of Bone and Mineral Research, 1999